Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunization. Update: search for an AIDS vaccine.

S Bende1, M I Johnston

  • 1Vaccine and Prevention Research Program, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Md., USA.

The AIDS Reader
|October 6, 2000
PubMed
Summary

Developing an effective HIV vaccine remains a top priority. This research outlines the scientific challenges, clinical trial outcomes, and future directions for creating a successful human immunodeficiency virus (HIV) preventive vaccine.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Publish and Be Sued? Potential Liability for Infringement Arising through Academic Research.

Tissue engineering·2009
Same author

HIV vaccine development.

Developments in biologicals·2002
Same author

Progress in HIV vaccine development.

Current opinion in pharmacology·2002
Same author

Optimism is growing as researchers move toward an AIDS vaccine.

AIDS alert·2001
Same author

Season of birth in females with anorexia nervosa in Northeast Scotland.

The International journal of eating disorders·2001
Same author

The role of nonhuman primate models in AIDS vaccine development.

Molecular medicine today·2000

Area of Science:

  • Immunology
  • Vaccinology
  • Infectious Diseases

Background:

  • Human immunodeficiency virus (HIV) prevention is a global health priority.
  • Current HIV therapies offer hope but do not halt worldwide epidemic spread.
  • Development of a safe and effective HIV vaccine is crucial for global control.

Purpose of the Study:

  • To identify and discuss scientific and logistical obstacles in HIV vaccine development.
  • To provide an overview of current progress and future research priorities.

Main Methods:

  • Review of scientific literature and research findings.
  • Synopsis of clinical trial data.
  • Analysis of preclinical research outcomes.

Main Results:

Related Experiment Videos

  • Significant scientific and technical challenges impede HIV vaccine development.
  • Clinical trials have yielded mixed results, highlighting the complexity of inducing protective immunity.
  • Recent preclinical studies show promising avenues but require further validation.

Conclusions:

  • Overcoming existing obstacles is essential for advancing HIV vaccine research.
  • Continued investment in preclinical and clinical research is vital.
  • Future priorities include novel immunogen design and innovative trial strategies.